{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:54:28Z","timestamp":1775732068593,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","award":["XLYC2007096"],"award-info":[{"award-number":["XLYC2007096"]}],"id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00772-w","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:06:53Z","timestamp":1775228813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MiR-142-3p promotes radioresistance by targeting FOXO4 in colorectal cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Xi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Xi","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"2","key":"772_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","volume":"43","author":"R Abedizadeh","year":"2024","unstructured":"Abedizadeh R, Majidi F, Khorasani HR, Abedi H, Sabour D. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer Metastasis Rev. 2024;43(2):729\u201353.","journal-title":"Cancer Metastasis Rev"},{"key":"772_CR2","doi-asserted-by":"publisher","first-page":"101839","DOI":"10.1016\/j.bpg.2023.101839","volume":"66","author":"L Klimeck","year":"2023","unstructured":"Klimeck L, Heisser T, Hoffmeister M, Brenner H. Colorectal cancer: A health and economic problem. Best Pract Res Clin Gastroenterol. 2023;66:101839.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"10207","key":"772_CR3","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467\u201380.","journal-title":"Lancet"},{"issue":"Suppl 3","key":"772_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/annonc\/11.suppl_3.45","volume":"11","author":"H Wilke","year":"2000","unstructured":"Wilke H, Stahl M. Colorectal cancer and metastasectomy: treatment of advanced disease. Ann Oncol. 2000;11(Suppl 3):45\u20139.","journal-title":"Ann Oncol"},{"issue":"4","key":"772_CR5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa2303269","volume":"389","author":"D Schrag","year":"2023","unstructured":"Schrag D, Shi Q, Weiser MR, Gollub MJ, Saltz LB, Musher BL, Goldberg J, Al Baghdadi T, Goodman KA, McWilliams RR, et al. Preoperative Treatment of Locally Advanced Rectal Cancer. N Engl J Med. 2023;389(4):322\u201334.","journal-title":"N Engl J Med"},{"issue":"17","key":"772_CR6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, R\u00f6del C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731\u201340.","journal-title":"N Engl J Med"},{"issue":"1","key":"772_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92\u2013105.","journal-title":"Genome Res"},{"issue":"4","key":"772_CR8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","volume":"136","author":"RW Carthew","year":"2009","unstructured":"Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell. 2009;136(4):642\u201355.","journal-title":"Cell"},{"issue":"4","key":"772_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"772_CR10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.neo.2019.07.005","volume":"21","author":"HT Ha Thi","year":"2019","unstructured":"Ha Thi HT, Kim HY, Kim YM, Hong S. MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4. Neoplasia. 2019;21(9):882\u201392.","journal-title":"Neoplasia"},{"issue":"5654","key":"772_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1126\/science.1091903","volume":"303","author":"CZ Chen","year":"2004","unstructured":"Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303(5654):83\u20136.","journal-title":"Science"},{"issue":"5","key":"772_CR12","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1159\/000358700","volume":"33","author":"G Xu","year":"2014","unstructured":"Xu G, Wang J, Jia Y, Shen F, Han W, Kang Y. MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1. Cell Physiol Biochem. 2014;33(5):1329\u201339.","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"772_CR13","first-page":"2346","volume":"21","author":"M Li","year":"2017","unstructured":"Li M, Li BY, Xia H, Jiang LL. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis. Eur Rev Med Pharmacol Sci. 2017;21(10):2346\u201350.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"772_CR14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.bbrc.2018.01.112","volume":"496","author":"S Hua","year":"2018","unstructured":"Hua S, Liu C, Liu L, Wu D. miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA. Biochem Biophys Res Commun. 2018;496(3):947\u201354.","journal-title":"Biochem Biophys Res Commun"},{"key":"772_CR15","doi-asserted-by":"crossref","unstructured":"Isobe T, Hisamori S, Hogan DJ, Zabala M, Hendrickson DG, Dalerba P, Cai S, Scheeren F, Kuo AH, Sikandar SS et al. miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway. Elife. 2014;3.","DOI":"10.7554\/eLife.01977"},{"issue":"9","key":"772_CR16","doi-asserted-by":"publisher","first-page":"e0136913","DOI":"10.1371\/journal.pone.0136913","volume":"10","author":"A Shrestha","year":"2015","unstructured":"Shrestha A, Carraro G, El Agha E, Mukhametshina R, Chao CM, Rizvanov A, Barreto G, Bellusci S. Generation and Validation of miR-142 Knock Out Mice. PLoS ONE. 2015;10(9):e0136913.","journal-title":"PLoS ONE"},{"issue":"6","key":"772_CR17","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41416-018-0254-z","volume":"119","author":"H Li","year":"2018","unstructured":"Li H, Li F. Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p. Br J Cancer. 2018;119(6):744\u201355.","journal-title":"Br J Cancer"},{"issue":"3","key":"772_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/mc.22935","volume":"58","author":"J Lawson","year":"2019","unstructured":"Lawson J, Dickman C, Towle R, Jabalee J, Javer A, Garnis C. Extracellular vesicle secretion of miR-142-3p from lung adenocarcinoma cells induces tumor promoting changes in the stroma through cell-cell communication. Mol Carcinog. 2019;58(3):376\u201387.","journal-title":"Mol Carcinog"},{"issue":"6","key":"772_CR19","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.7150\/jca.41888","volume":"11","author":"YF Tan","year":"2020","unstructured":"Tan YF, Chen ZY, Wang L, Wang M, Liu XH. MiR-142-3p functions as an oncogene in prostate cancer by targeting FOXO1. J Cancer. 2020;11(6):1614\u201324.","journal-title":"J Cancer"},{"issue":"3","key":"772_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10555-020-09883-w","volume":"39","author":"Y Jiramongkol","year":"2020","unstructured":"Jiramongkol Y, Lam EW. FOXO transcription factor family in cancer and metastasis. Cancer Metastasis Rev. 2020;39(3):681\u2013709.","journal-title":"Cancer Metastasis Rev"},{"key":"772_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2018.01.004","volume":"50","author":"RK Yadav","year":"2018","unstructured":"Yadav RK, Chauhan AS, Zhuang L, Gan B. FoxO transcription factors in cancer metabolism. Semin Cancer Biol. 2018;50:65\u201376.","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"772_CR22","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrc2223","volume":"7","author":"SS Myatt","year":"2007","unstructured":"Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007;7(11):847\u201359.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"772_CR23","doi-asserted-by":"publisher","first-page":"26880","DOI":"10.3390\/ijms161125991","volume":"16","author":"BM Kim","year":"2015","unstructured":"Kim BM, Hong Y, Lee S, Liu P, Lim JH, Lee YH, Lee TH, Chang KT, Hong Y. Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy. Int J Mol Sci. 2015;16(11):26880\u2013913.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"772_CR24","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.tips.2022.09.010","volume":"43","author":"A Orea-Soufi","year":"2022","unstructured":"Orea-Soufi A, Paik J, Bragan\u00e7a J, Donlon TA, Willcox BJ, Link W. FOXO transcription factors as therapeutic targets in human diseases. Trends Pharmacol Sci. 2022;43(12):1070\u201384.","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"772_CR25","first-page":"969","volume":"27","author":"L Xiang-qiang","year":"2011","unstructured":"Xiang-qiang L, Shan-hong T. Zhi-yong Z, Hai-feng J: [Expression and clinical significance of FOX04 in colorectal cancer]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011;27(9):969\u201371.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"772_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.critrevonc.2016.11.017","volume":"109","author":"J Lacombe","year":"2017","unstructured":"Lacombe J, Zenhausern F. Emergence of miR-34a in radiation therapy. Crit Rev Oncol Hematol. 2017;109:69\u201378.","journal-title":"Crit Rev Oncol Hematol"},{"key":"772_CR27","doi-asserted-by":"publisher","first-page":"110580","DOI":"10.1016\/j.cellsig.2022.110580","volume":"104","author":"L Darvish","year":"2023","unstructured":"Darvish L, Bahreyni Toossi MT, Azimian H, Shakeri M, Dolat E, Ahmadizad Firouzjaei A, Rezaie S, Amraee A, Aghaee-Bakhtiari SH. The role of microRNA-induced apoptosis in diverse radioresistant cancers. Cell Signal. 2023;104:110580.","journal-title":"Cell Signal"},{"key":"772_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dnarep.2016.09.003","volume":"47","author":"M Majidinia","year":"2016","unstructured":"Majidinia M, Yousefi B. DNA damage response regulation by microRNAs as a therapeutic target in cancer. DNA Repair (Amst). 2016;47:1\u201311.","journal-title":"DNA Repair (Amst)"},{"issue":"2","key":"772_CR29","first-page":"545","volume":"5","author":"XD Yang","year":"2015","unstructured":"Yang XD, Xu XH, Zhang SY, Wu Y, Xing CG, Ru G, Xu HT, Cao JP. Role of miR-100 in the radioresistance of colorectal cancer cells. Am J Cancer Res. 2015;5(2):545\u201359.","journal-title":"Am J Cancer Res"},{"issue":"6","key":"772_CR30","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.stemcr.2018.10.015","volume":"11","author":"D Ji","year":"2018","unstructured":"Ji D, Zhan T, Li M, Yao Y, Jia J, Yi H, Qiao M, Xia J, Zhang Z, Ding H, et al. Enhancement of Sensitivity to Chemo\/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer. Stem Cell Rep. 2018;11(6):1506\u201322.","journal-title":"Stem Cell Rep"},{"issue":"5","key":"772_CR31","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s11684-024-1082-6","volume":"18","author":"Q Lu","year":"2024","unstructured":"Lu Q, Ren N, Chen H, Zhang S, Yan R, Li M, Zheng L, Tan W, Lin D. Polymorphism in the Hsa-miR-4274 seed region influences the expression of PEX5 and enhances radiotherapy resistance in colorectal cancer. Front Med. 2024;18(5):921\u201337.","journal-title":"Front Med"},{"key":"772_CR32","doi-asserted-by":"publisher","first-page":"216651","DOI":"10.1016\/j.canlet.2024.216651","volume":"587","author":"R Tang","year":"2024","unstructured":"Tang R, Yin J, Liu Y, Xue J. FLASH radiotherapy: A new milestone in the field of cancer radiotherapy. Cancer Lett. 2024;587:216651.","journal-title":"Cancer Lett"},{"key":"772_CR33","doi-asserted-by":"crossref","unstructured":"Lodovichi S, Cervelli T, Pellicioli A, Galli A. Inhibition of DNA repair in cancer therapy: toward a multi-target approach. Int J Mol Sci. 2020;21(18).","DOI":"10.3390\/ijms21186684"},{"issue":"4","key":"772_CR34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1139\/O07-069","volume":"85","author":"RS Williams","year":"2007","unstructured":"Williams RS, Williams JS, Tainer JA. Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template. Biochem Cell Biol. 2007;85(4):509\u201320.","journal-title":"Biochem Cell Biol"},{"key":"772_CR35","doi-asserted-by":"publisher","first-page":"102917","DOI":"10.1016\/j.dnarep.2020.102917","volume":"93","author":"RE London","year":"2020","unstructured":"London RE. XRCC1 - Strategies for coordinating and assembling a versatile DNA damage response. DNA Repair (Amst). 2020;93:102917.","journal-title":"DNA Repair (Amst)"},{"issue":"9","key":"772_CR36","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1093\/nar\/gkab269","volume":"49","author":"S Kumamoto","year":"2021","unstructured":"Kumamoto S, Nishiyama A, Chiba Y, Miyashita R, Konishi C, Azuma Y, Nakanishi M. HPF1-dependent PARP activation promotes LIG3-XRCC1-mediated backup pathway of Okazaki fragment ligation. Nucleic Acids Res. 2021;49(9):5003\u201316.","journal-title":"Nucleic Acids Res"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00772-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00772-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00772-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:57:32Z","timestamp":1775728652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00772-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00772-w","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"20 C-NKG mice were purchased from Cyagen Biosciences Inc., Suzhou, China, and the study protocol was approved by the Institutional.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All experimental procedures were approved by the Animal Protection Committee of Jinzhou Medical University (No. Approval: 250229-5) and conducted in accordance with the National Guidelines for Animal Protection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}